Skip to main content

stock

BLTE · BELITE BIO, INC

What BELITE BIO, INC reports to the SEC, read from its filings.

Open in the app

Price

The live BLTE price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BLTE.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
39,339,960 as of 2025-12-31 (XBRL frame CY2025Q4I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
—

Health

Current ratio
50.0x
Debt/equity
—

Deep value

NCAV
$484.20M
NCAV per share
$12.31
Price/NCAV
Locked
NNWC
$342.86M
NNWC per share
$8.72
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to —; balance sheet at 2025-12-31.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

No quarterly results reported by SEC for this filer.

Assets
$780.56M
Equity
$770.49M

Balance as of 2025-12-31.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$84.21M-$77.61M-$37.06M
2024-12-31—-$40.00M-$36.14M-$29.35M
2023-12-31—-$31.67M-$31.63M-$29.90M
2022-12-31—-$12.82M-$12.65M-$11.85M
2021-12-31—-$9.80M-$9.67M-$7.55M
2020-12-31—-$5.74M-$5.75M—

Company filings

since Wed Oct 22 · 2 offering filings in 12 months

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named BLTE, and the market events around them.

Sign in to see this

Board

The BLTE board could not be loaded.

Retry the BLTE board

nakagai

Signals on BLTE come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BLTE board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

BELITE BIO, INC (BLTE): SEC filings, financials and insider trades · Nakagai